| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.4 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.4 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.4 |